Antoniotti C, Borelli B, Rossini D, Pietrantonio F, et al. AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer. BMC Cancer 2020;20:683.
PMID: 32698790